iRay Technology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

iRay Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, iRay Technology Co Ltd (688301) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥343.82 Million ≈ $50.31 Million USD) by net assets (CN¥6.07 Billion ≈ $888.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of iRay Technology Co Ltd (2015–2024)

Cash flow conversion efficiency of iRay Technology Co Ltd from 2015 to 2024. This chart illustrates how iRay Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View iRay Technology Co Ltd stock quote for real-time trading data and today's change.

iRay Technology Co Ltd Cash Flow Conversion Ratio Explained

iRay Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

iRay Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iRay Technology Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of iRay Technology Co Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Newell Brands Inc
NASDAQ:NWL
0.012x
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
-0.014x
China Suntien Green Energy Corp Ltd
SHG:600956
0.093x
Shufersal
TA:SAE
0.022x
Shenzhen FRD Science & Technology Co Ltd
SHE:300602
0.042x
PT Golden Energy Mines Tbk
JK:GEMS
0.053x
LG Household & Healthcare
KO:051900
0.016x
AddLife AB (publ)
ST:ALIF-B
0.029x

Annual Cash Flow Conversion Efficiency for iRay Technology Co Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of iRay Technology Co Ltd from 2015 to 2024. Review 688301 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.65 Billion
≈ $679.92 Million
CN¥360.42 Million
≈ $52.74 Million
0.078x -0.78%
2023-12-31 CN¥4.35 Billion
≈ $636.98 Million
CN¥340.32 Million
≈ $49.80 Million
0.078x -3.61%
2022-12-31 CN¥3.90 Billion
≈ $571.23 Million
CN¥316.62 Million
≈ $46.33 Million
0.081x +0.61%
2021-12-31 CN¥3.08 Billion
≈ $450.20 Million
CN¥248.02 Million
≈ $36.29 Million
0.081x -19.06%
2020-12-31 CN¥2.63 Billion
≈ $385.41 Million
CN¥262.32 Million
≈ $38.39 Million
0.100x +37.74%
2019-12-31 CN¥425.61 Million
≈ $62.28 Million
CN¥30.78 Million
≈ $4.50 Million
0.072x +24.07%
2018-12-31 CN¥331.02 Million
≈ $48.44 Million
CN¥19.29 Million
≈ $2.82 Million
0.058x -85.59%
2017-12-31 CN¥251.42 Million
≈ $36.79 Million
CN¥101.68 Million
≈ $14.88 Million
0.404x +79.20%
2016-12-31 CN¥177.70 Million
≈ $26.00 Million
CN¥40.10 Million
≈ $5.87 Million
0.226x -52.01%
2015-12-31 CN¥134.92 Million
≈ $19.74 Million
CN¥63.45 Million
≈ $9.28 Million
0.470x --

About iRay Technology Co Ltd

SHG:688301 China Medical Instruments & Supplies
Market Cap
$2.33 Billion
CN¥15.92 Billion CNY
Market Cap Rank
#5476 Global
#953 in China
Share Price
CN¥75.27
Change (1 day)
-5.32%
52-Week Range
CN¥71.30 - CN¥205.77
All Time High
CN¥278.84
About

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-r… Read more